MYCN amplification drives an aggressive form of spinal ependymoma. https://t.co/YF5089CKzh
MYCN amplification drives an aggressive form of spinal ependymoma. https://t.co/CFG8mHQR5c
RT @brainpathol: 7) #Ependymoma will now be categorized by anatomic site. (a) Supratentorial ependymoma: RELA fusion-positive (WHO 2016), Y…
7) #Ependymoma will now be categorized by anatomic site. (a) Supratentorial ependymoma: RELA fusion-positive (WHO 2016), YAP1-MAMLD1 fusion positive. (b) Posterior fossa: type A, type B. (c) Spinal: MYCN-amplified (NEW!) https://t.co/b6rQNzkIjs
RT @ucl_discovery: Open Access UCL Research: MYCN amplification drives an aggressive form of spinal ependymoma https://t.co/q92tSF4VEH
Open Access UCL Research: MYCN amplification drives an aggressive form of spinal ependymoma https://t.co/q92tSF4VEH
RT @Sty_md: It's out ! https://t.co/IVIw2vqSnb https://t.co/pRIaXDSJrG
It's out ! https://t.co/IVIw2vqSnb https://t.co/pRIaXDSJrG
Great work by Kristian Pajtler and colleagues @DKFZ identifying an aggressive Ependymoma subgroup, characterized by focal MYCN amplifications. https://t.co/xVTHtU9ah6
RT @NeuropathClinic: MYCN amplification drives an aggressive form of spinal ependymoma. #neuropath https://t.co/tA0OK8oENm
RT @NeuropathClinic: MYCN amplification drives an aggressive form of spinal ependymoma. #neuropath https://t.co/tA0OK8oENm
MYCN amplification drives an aggressive form of spinal ependymoma. #neuropath https://t.co/tA0OK8oENm